Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 3
2006 5
2007 3
2008 1
2009 1
2010 6
2011 7
2012 1
2013 3
2014 1
2015 6
2016 2
2017 1
2018 3
2019 6
2020 3
2021 5
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study.
Edelmann F, Gelbrich G, Düngen HD, Fröhling S, Wachter R, Stahrenberg R, Binder L, Töpper A, Lashki DJ, Schwarz S, Herrmann-Lingen C, Löffler M, Hasenfuss G, Halle M, Pieske B. Edelmann F, et al. Among authors: binder l. J Am Coll Cardiol. 2011 Oct 18;58(17):1780-91. doi: 10.1016/j.jacc.2011.06.054. J Am Coll Cardiol. 2011. PMID: 21996391 Free article. Clinical Trial.
Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W, Duvinage A, Stahrenberg R, Durstewitz K, Löffler M, Düngen HD, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbrich G, Pieske B; Aldo-DHF Investigators. Edelmann F, et al. JAMA. 2013 Feb 27;309(8):781-91. doi: 10.1001/jama.2013.905. JAMA. 2013. PMID: 23443441 Clinical Trial.
Advances in endothelial shear stress proteomics.
Firasat S, Hecker M, Binder L, Asif AR. Firasat S, et al. Among authors: binder l. Expert Rev Proteomics. 2014 Oct;11(5):611-9. doi: 10.1586/14789450.2014.933673. Epub 2014 Jul 12. Expert Rev Proteomics. 2014. PMID: 25017810 Review.
Macro-CK type 2 in metastatic prostate cancer.
Eidizadeh A, von Ahsen N, Friedewald S, Binder L. Eidizadeh A, et al. Among authors: binder l. Diagnosis (Berl). 2019 Aug 27;6(3):307-309. doi: 10.1515/dx-2018-0039. Diagnosis (Berl). 2019. PMID: 30412465
Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial.
Schnelle M, Leha A, Eidizadeh A, Fuhlrott K, Trippel TD, Hashemi D, Toischer K, Wachter R, Herrmann-Lingen C, Hasenfuß G, Pieske B, Binder L, Edelmann F. Schnelle M, et al. Among authors: binder l. Cells. 2021 Oct 19;10(10):2796. doi: 10.3390/cells10102796. Cells. 2021. PMID: 34685778 Free PMC article. Clinical Trial.
The diagnostic and prognostic value of galectin-3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST-CHF study.
Trippel TD, Mende M, Düngen HD, Hashemi D, Petutschnigg J, Nolte K, Herrmann-Lingen C, Binder L, Hasenfuss G, Pieske B, Wachter R, Edelmann F. Trippel TD, et al. Among authors: binder l. ESC Heart Fail. 2021 Apr;8(2):829-841. doi: 10.1002/ehf2.13174. Epub 2021 Feb 10. ESC Heart Fail. 2021. PMID: 33566456 Free PMC article.
55 results